Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

James Falko to Cholesterol

This is a "connection" page, showing publications James Falko has written about Cholesterol.

 
Connection Strength
 
 
 
0.181
 
  1. Falko JM, O'Dorisio TM, Cataland S. Improvement of high-density lipoprotein-cholesterol levels. Ambulatory type I diabetics treated with the subcutaneous insulin pump. JAMA. 1982 Jan 01; 247(1):37-9.
    View in: PubMed
    Score: 0.043
  2. Falko JM, Witztum JL, Schonfeld G, Bateman J. Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterol. Ann Intern Med. 1979 Nov; 91(5):750-1.
    View in: PubMed
    Score: 0.037
  3. Meis SB, Snow R, Lalonde M, Falko J, Caulin-Glaser T. A systematic approach to improve lipids in coronary artery disease patients participating in a cardiac rehabilitation program. J Cardiopulm Rehabil. 2006 Nov-Dec; 26(6):355-60; quiz 361-2.
    View in: PubMed
    Score: 0.015
  4. Patel ST, Newman HA, Yates AJ, Thibert P, Falko JM. Serum lipids and lipoprotein composition in spontaneously diabetic BB Wistar rats. J Lipid Res. 1984 Oct; 25(10):1072-83.
    View in: PubMed
    Score: 0.013
  5. Bossetti BM, Kocher LM, Moranz JF, Falko JM. The effects of physiologic amounts of simple sugars on lipoprotein, glucose, and insulin levels in normal subjects. Diabetes Care. 1984 Jul-Aug; 7(4):309-12.
    View in: PubMed
    Score: 0.013
  6. Yovos JG, Patel ST, Falko JM, Newman HA, Hill DS. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia. J Clin Endocrinol Metab. 1982 Jun; 54(6):1210-5.
    View in: PubMed
    Score: 0.011
  7. Falko JM. High density lipoprotein (HDL): a protective lipoprotein. Ohio State Med J. 1980 Aug; 76(8):513-5.
    View in: PubMed
    Score: 0.010
  8. Falko JM, Schonfeld G, Witztum JL, Kolar JB, Salmon P. Effects of short-term high carbohydrate, fat-free diet on plasma levels of Apo C-II and Apo C-III and on the Apo C subspecies in human plasma lipoproteins. Metabolism. 1980 Jul; 29(7):654-61.
    View in: PubMed
    Score: 0.010
  9. Falko JM, Schonfeld G, Witztum JL, Kolar J, Weidman SW. Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia. Metabolism. 1979 Nov; 28(11):1171-7.
    View in: PubMed
    Score: 0.009
  10. Falko JM, Williams JC, Harvey DG, Weidman SW, Schonfeld G, Dodson WE. Hyperlipoproteinemia and multifocal neurologic dysfunction in systemic lupus erythematosus. J Pediatr. 1979 Oct; 95(4):523-9.
    View in: PubMed
    Score: 0.009
  11. Falko JM, Witztum JL, Schonfeld G, Weidman SW, Kolar JB. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy. Am J Med. 1979 Feb; 66(2):303-10.
    View in: PubMed
    Score: 0.009
  12. Friedman CI, Falko JM, Patel ST, Kim MH, Newman HA, Barrows H. Serum lipoprotein responses during active and stable weight reduction in reproductive obese females. J Clin Endocrinol Metab. 1982 Aug; 55(2):258-62.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)